Mesenchymal Stem Cells Modulate Light-induced Activation of Retinal Microglia Through CX3CL1/CX3CR1 Signaling

Libin Huang1, Guoxing Xu1, Jian Guo1

  • 1a Department of Ophthalmology , First Affiliated Hospital of Fujian Medical University , Fuzhou , China.

Abstract

Insights

Mesenchymal stem cells (MSCs) restore retinal microglia function after light damage by modulating CX3CL1/CX3CR1 signaling. This interaction reduces inflammation and enhances neuroprotection, promoting visual health.

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Immunology

Background:

  • Retinal microglia play a crucial role in maintaining visual homeostasis.
  • Light-induced damage can activate microglia, leading to inflammation and neurodegeneration.
  • Mesenchymal stem cells (MSCs) have immunomodulatory properties with potential therapeutic applications in retinal diseases.

Purpose of the Study:

  • To investigate the role of CX3CL1/CX3CR1 signaling in the interaction between MSCs and retinal microglia.
  • To determine how MSCs influence the function of light-damaged retinal microglia.
  • To elucidate the therapeutic potential of MSCs in light-induced retinal injury.

Main Methods:

  • Retinal microglia were stimulated with supernatants from light-damaged rat retinas.
  • Stimulated microglia were co-cultured with MSCs, CX3CL1-overexpressing MSCs, or MSCs with blocked CX3CL1.
  • Molecular and functional changes in microglia were analyzed, including cytokine expression and cell behavior.

Main Results:

  • MSCs inhibited pro-inflammatory factors and increased neurotrophic factors in activated microglia.
  • MSCs modulated microglial proliferation, migration, and phagocytosis.
  • CX3CL1/CX3CR1 signaling significantly influenced the effects of MSCs on microglia, with enhanced effects seen with CX3CL1-overexpressing MSCs.

Conclusions:

  • MSCs restore homeostatic functions of retinal microglia following light-induced damage.
  • The CX3CL1/CX3CR1 signaling pathway is a key mechanism mediating MSC therapeutic effects on retinal microglia.
  • Targeting this pathway holds promise for treating retinal inflammatory conditions.